High-Level Overview
MedCrypt is a cybersecurity company founded in 2016 that provides medical device manufacturers (MDMs) with a self-service SaaS platform and consulting services to embed cybersecurity features directly into medical devices. Their flagship product, the Medical Device Product Security Intelligence Platform, helps MDMs assess security posture, identify vulnerabilities, quantify cybersecurity risks in financial terms, and generate cost-aligned remediation plans quickly. MedCrypt serves medical device vendors developing connected or software-enabled devices, enabling them to meet FDA cybersecurity requirements, protect patient safety, and accelerate time to market with secure-by-design technologies. The company’s integrated approach combines scalable software tools with expert regulatory consulting, positioning it as a key enabler in the medtech cybersecurity space[1][3][4][6].
Origin Story
MedCrypt was co-founded in 2016 by Eric Pancoast and Mike Kijewski, both with backgrounds in healthcare technology and cybersecurity. Prior to MedCrypt, they co-founded Gamma Basics, a radiation oncology software company acquired by Varian Medical Systems in 2013. The idea for MedCrypt emerged from their desire to build security tooling specifically for medical device companies to ensure devices are secure by design (SbD). Early traction came from addressing the growing regulatory and market demand for medical device cybersecurity solutions, especially as FDA guidance on cybersecurity became more stringent[1][4].
Core Differentiators
- Product Differentiators: MedCrypt’s platform uniquely translates cybersecurity gaps into financial impact, helping executives make informed decisions by benchmarking security maturity across device classes and tying risks to dollar values. It also offers real-time monitoring through a network that uses machine learning to detect malicious behavior and facilitates threat sharing among device vendors[1][2][4].
- Developer Experience: The self-service SaaS model allows medical device teams to quickly evaluate and remediate security issues without heavy reliance on external consultants, accelerating go-to-market timelines.
- Integrated Consulting: MedCrypt combines technology with strategic management consulting led by ex-FDA reviewers, providing regulatory strategy and compliance guidance alongside technical tools[3][5].
- Community Ecosystem: By centralizing transaction data and enabling threat sharing, MedCrypt fosters a collaborative ecosystem among medical device manufacturers to collectively improve security[2].
Role in the Broader Tech Landscape
MedCrypt rides the critical trend of increasing cybersecurity requirements in healthcare, particularly for connected medical devices (Internet of Medical Things - IoMT). The timing is crucial as regulatory bodies like the FDA impose stricter premarket and postmarket cybersecurity standards, making security a strategic business imperative rather than an afterthought. Market forces such as the proliferation of networked medical devices, rising cyber threats, and the high cost of breaches drive demand for integrated, scalable security solutions. MedCrypt influences the ecosystem by enabling manufacturers to embed security early in the design process, thus improving patient safety, regulatory compliance, and trust in digital health technologies[1][3][4][6].
Quick Take & Future Outlook
MedCrypt is poised for continued growth fueled by regulatory pressure and the expanding connected device market. Future trends shaping its journey include evolving cybersecurity regulations globally, increasing adoption of AI-driven threat detection, and broader industry collaboration on threat intelligence. MedCrypt’s influence is likely to deepen as it further integrates financial risk analytics with security management, helping medical device companies balance innovation speed with robust cybersecurity. This positions MedCrypt as a vital partner in the ongoing transformation of healthcare technology toward secure, compliant, and trustworthy digital health solutions[4][9].
